| Salman Akhtar, MD | |
|
7020 Smoke Ranch Rd Ste 150, Las Vegas, NV 89128 | |
| (702) 366-9522 | |
| (702) 341-5206 |
| Full Name | Salman Akhtar |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 37 Years |
| Location | 7020 Smoke Ranch Rd Ste 150, Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639168966 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 8926 (Nevada) | Primary |
| 207RI0011X | Internal Medicine - Interventional Cardiology | 8926 (Nevada) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southern Hills Hospital And Medical Center | Las vegas, NV | Hospital |
| Mountainview Hospital | Las vegas, NV | Hospital |
| Spring Valley Hospital Medical Center | Las vegas, NV | Hospital |
| Summerlin Hospital Medical Center | Las vegas, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prime Cardiology Group | 5890123046 | 16 |
News Archive
The New York Times reports that safety rules for biotechnology workers sometimes expose them to dangerous pathogens. "Whether handling deadly pathogens for biowarfare research, harnessing viruses to do humankind's bidding or genetically transforming cells to give them powers not found in nature, the estimated 232,000 employees in the nation's most sophisticated biotechnology labs work amid imponderable hazards. And some critics say the modern biolab often has fewer federal safety regulations than a typical blue-collar factory."
BRCA1 and BRCA2 are two genes that have been identified to hold a key to women's susceptibility to get breast or ovarian cancer. Changes also known as mutations in these genes are significant in women who go on to develop breast or ovarian cancer. Melbourne-based company Genetic Technologies Limited (GTL) has the exclusive license from American biotechnology company Myriad Genetics to carry out testing for the genes in Australia. Myriad holds a patent for these genes.
Translate Bio, a clinical-stage messenger RNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction, announced today a multi-year research and development collaboration and exclusive licensing agreement with Sanofi Pasteur, the vaccines global business unit of Sanofi, to develop mRNA vaccines for up to five undisclosed infectious disease pathogens.
Officials have confirmed that a new statewide prescription assistance program, called Wyoming Rx Card, is being launched tomorrow. The program will provide free discount prescription drug cards to Wyoming residents.
The UK's first weight loss App that scans barcodes on food products has been launched by Nutracheck.co.uk.
› Verified 6 days ago
| Entity Name | Salman Akhtar Md Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780895789 PECOS PAC ID: 8426159989 Enrollment ID: O20070727000321 |
News Archive
The New York Times reports that safety rules for biotechnology workers sometimes expose them to dangerous pathogens. "Whether handling deadly pathogens for biowarfare research, harnessing viruses to do humankind's bidding or genetically transforming cells to give them powers not found in nature, the estimated 232,000 employees in the nation's most sophisticated biotechnology labs work amid imponderable hazards. And some critics say the modern biolab often has fewer federal safety regulations than a typical blue-collar factory."
BRCA1 and BRCA2 are two genes that have been identified to hold a key to women's susceptibility to get breast or ovarian cancer. Changes also known as mutations in these genes are significant in women who go on to develop breast or ovarian cancer. Melbourne-based company Genetic Technologies Limited (GTL) has the exclusive license from American biotechnology company Myriad Genetics to carry out testing for the genes in Australia. Myriad holds a patent for these genes.
Translate Bio, a clinical-stage messenger RNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction, announced today a multi-year research and development collaboration and exclusive licensing agreement with Sanofi Pasteur, the vaccines global business unit of Sanofi, to develop mRNA vaccines for up to five undisclosed infectious disease pathogens.
Officials have confirmed that a new statewide prescription assistance program, called Wyoming Rx Card, is being launched tomorrow. The program will provide free discount prescription drug cards to Wyoming residents.
The UK's first weight loss App that scans barcodes on food products has been launched by Nutracheck.co.uk.
› Verified 6 days ago
| Entity Name | Prime Cardiology Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730710807 PECOS PAC ID: 5890123046 Enrollment ID: O20200321000456 |
News Archive
The New York Times reports that safety rules for biotechnology workers sometimes expose them to dangerous pathogens. "Whether handling deadly pathogens for biowarfare research, harnessing viruses to do humankind's bidding or genetically transforming cells to give them powers not found in nature, the estimated 232,000 employees in the nation's most sophisticated biotechnology labs work amid imponderable hazards. And some critics say the modern biolab often has fewer federal safety regulations than a typical blue-collar factory."
BRCA1 and BRCA2 are two genes that have been identified to hold a key to women's susceptibility to get breast or ovarian cancer. Changes also known as mutations in these genes are significant in women who go on to develop breast or ovarian cancer. Melbourne-based company Genetic Technologies Limited (GTL) has the exclusive license from American biotechnology company Myriad Genetics to carry out testing for the genes in Australia. Myriad holds a patent for these genes.
Translate Bio, a clinical-stage messenger RNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction, announced today a multi-year research and development collaboration and exclusive licensing agreement with Sanofi Pasteur, the vaccines global business unit of Sanofi, to develop mRNA vaccines for up to five undisclosed infectious disease pathogens.
Officials have confirmed that a new statewide prescription assistance program, called Wyoming Rx Card, is being launched tomorrow. The program will provide free discount prescription drug cards to Wyoming residents.
The UK's first weight loss App that scans barcodes on food products has been launched by Nutracheck.co.uk.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Salman Akhtar, MD 7020 Smoke Ranch Rd Ste 150, Las Vegas, NV 89128 Ph: (702) 366-9522 | Salman Akhtar, MD 7020 Smoke Ranch Rd Ste 150, Las Vegas, NV 89128 Ph: (702) 366-9522 |
News Archive
The New York Times reports that safety rules for biotechnology workers sometimes expose them to dangerous pathogens. "Whether handling deadly pathogens for biowarfare research, harnessing viruses to do humankind's bidding or genetically transforming cells to give them powers not found in nature, the estimated 232,000 employees in the nation's most sophisticated biotechnology labs work amid imponderable hazards. And some critics say the modern biolab often has fewer federal safety regulations than a typical blue-collar factory."
BRCA1 and BRCA2 are two genes that have been identified to hold a key to women's susceptibility to get breast or ovarian cancer. Changes also known as mutations in these genes are significant in women who go on to develop breast or ovarian cancer. Melbourne-based company Genetic Technologies Limited (GTL) has the exclusive license from American biotechnology company Myriad Genetics to carry out testing for the genes in Australia. Myriad holds a patent for these genes.
Translate Bio, a clinical-stage messenger RNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction, announced today a multi-year research and development collaboration and exclusive licensing agreement with Sanofi Pasteur, the vaccines global business unit of Sanofi, to develop mRNA vaccines for up to five undisclosed infectious disease pathogens.
Officials have confirmed that a new statewide prescription assistance program, called Wyoming Rx Card, is being launched tomorrow. The program will provide free discount prescription drug cards to Wyoming residents.
The UK's first weight loss App that scans barcodes on food products has been launched by Nutracheck.co.uk.
› Verified 6 days ago
Dr. Arshi A. Quadeer, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2545 S Bruce St Ste 200, Las Vegas, NV 89169 Phone: 702-732-2438 Fax: 702-737-5043 | |
Cherie Lin, D.O. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 3006 S Maryland Pkwy, Suite 400, Las Vegas, NV 89109 Phone: 702-369-5582 Fax: 702-369-1533 | |
Michael M Lee, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1800 W Charleston Blvd, Las Vegas, NV 89102 Phone: 702-921-6823 Fax: 702-549-5240 | |
Henry Palangdao Igid, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 653 N Town Center Dr Ste 402, Las Vegas, NV 89144 Phone: 702-243-7200 Fax: 702-243-7235 | |
Ian Adrian Fanoga Frani, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1800 W Charleston Blvd, Las Vegas, NV 89102 Phone: 702-383-2000 Fax: 702-383-3875 | |
Sein Tun, DO Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 620 Shadow Ln, Las Vegas, NV 89106 Phone: 702-388-4000 | |
Berge Jack Dadourian, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 400 S Rampart Blvd, Suite 240, Las Vegas, NV 89145 Phone: 702-906-1100 Fax: 702-906-1110 |